These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24081479)

  • 1. Scale considerations for selection of saccharide excipients for liquid formulations.
    Zhou R; Schlam RF; Yin S; Gandhi RB; Adams ML
    J Pharm Sci; 2011 Apr; 100(4):1605-6. PubMed ID: 24081479
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigation of freeze/thaw-related quality attributes of a liquid biopharmaceutical formulation: the role of saccharide excipients.
    Zhou R; Schlam RF; Yin S; Gandhi RB; Adams ML
    PDA J Pharm Sci Technol; 2012; 66(3):221-35. PubMed ID: 22634588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic studies of glass vial breakage for frozen formulations. I. Vial breakage caused by crystallizable excipient mannitol.
    Jiang G; Akers M; Jain M; Guo J; Distler A; Swift R; Wadhwa MV; Jameel F; Patro S; Freund E
    PDA J Pharm Sci Technol; 2007; 61(6):441-51. PubMed ID: 18410045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physico-chemical lyophilization behavior of mannitol, human serum albumin formulations.
    Hawe A; Friess W
    Eur J Pharm Sci; 2006 Jun; 28(3):224-32. PubMed ID: 16580820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physicochemical characterization of the freezing behavior of mannitol-human serum albumin formulations.
    Hawe A; Friess W
    AAPS PharmSciTech; 2006; 7(4):94. PubMed ID: 17285745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of freezing procedure and annealing on the physico-chemical properties and the formation of mannitol hydrate in mannitol-sucrose-NaCl formulations.
    Hawe A; Friess W
    Eur J Pharm Biopharm; 2006 Nov; 64(3):316-25. PubMed ID: 16875806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of water on the stability of lyophilized formulations with inositol and mannitol as excipients.
    Terakita A; Matsunaga H; Handa T
    Chem Pharm Bull (Tokyo); 2009 May; 57(5):459-63. PubMed ID: 19420775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations.
    Schüle S; Friess W; Bechtold-Peters K; Garidel P
    Eur J Pharm Biopharm; 2007 Jan; 65(1):1-9. PubMed ID: 17034996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of some hydrophilic excipients on the rate of gabapentin and baclofen lactamization in lyophilized formulations.
    Cutrignelli A; Denora N; Lopedota A; Trapani A; Laquintana V; Latrofa A; Trapani G; Liso G
    Int J Pharm; 2007 Mar; 332(1-2):98-106. PubMed ID: 17071027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients.
    Jorgensen L; Hostrup S; Moeller EH; Grohganz H
    Expert Opin Drug Deliv; 2009 Nov; 6(11):1219-30. PubMed ID: 19678792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of mannitol crystallization in mannitol-sucrose systems on LDH stability during freeze-drying.
    Al-Hussein A; Gieseler H
    J Pharm Sci; 2012 Jul; 101(7):2534-44. PubMed ID: 22535541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation on formulation and preparation of adenovirus encoding human endostatin lyophilized powders.
    Chen S; Guo D; Guo B; Liu J; Shen Y; Xu X; Huang W; Guo S
    Int J Pharm; 2012 May; 427(2):145-52. PubMed ID: 22234038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classification of lyophilised mixtures using multivariate analysis of NIR spectra.
    Grohganz H; Fonteyne M; Skibsted E; Falck T; Palmqvist B; Rantanen J
    Eur J Pharm Biopharm; 2010 Feb; 74(2):406-12. PubMed ID: 19577644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients.
    Anhorn MG; Mahler HC; Langer K
    Int J Pharm; 2008 Nov; 363(1-2):162-9. PubMed ID: 18672043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous and scalable process for water-redispersible nanoformulation of poorly aqueous soluble APIs by antisolvent precipitation and spray-drying.
    Hu J; Ng WK; Dong Y; Shen S; Tan RB
    Int J Pharm; 2011 Feb; 404(1-2):198-204. PubMed ID: 21056643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of a screening method to determine excipients which optimize the extent and stability of supersaturated drug solutions and application of this system to solid formulation design.
    Vandecruys R; Peeters J; Verreck G; Brewster ME
    Int J Pharm; 2007 Sep; 342(1-2):168-75. PubMed ID: 17573214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The characterization and comparison of spray-dried mannitol samples.
    Hulse WL; Forbes RT; Bonner MC; Getrost M
    Drug Dev Ind Pharm; 2009 Jun; 35(6):712-8. PubMed ID: 19514986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid solid-state analysis of freeze-dried protein formulations using NIR and Raman spectroscopies.
    Grohganz H; Gildemyn D; Skibsted E; Flink JM; Rantanen J
    J Pharm Sci; 2011 Jul; 100(7):2871-5. PubMed ID: 21259241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adhesion and redistribution of salmeterol xinafoate particles in sugar-based mixtures for inhalation.
    Adi H; Larson I; Stewart PJ
    Int J Pharm; 2007 Jun; 337(1-2):229-38. PubMed ID: 17303354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical characterisation of formulations for the development of two stable freeze-dried proteins during both dried and liquid storage.
    Passot S; Fonseca F; Alarcon-Lorca M; Rolland D; Marin M
    Eur J Pharm Biopharm; 2005 Aug; 60(3):335-48. PubMed ID: 15894475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.